Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;33(6):e14301.
doi: 10.1111/dth.14301. Epub 2020 Sep 22.

Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau

Federico Bardazzi  1 , Ambra Di Altobrando  1 , Rossella Lacava  1
Affiliations

Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau

Federico Bardazzi et al. Dermatol Ther. 2020 Nov.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Smirnova LM, Vertieva EY, Olisova OY, Anpilogova EM. Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau. Biol Theory. 2019;13:83-87.
    1. Rubio C, Martin MA, Arranz Sánchez DM, Vidaurrazaga C, Casado M. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau. J Eur Acad Dermatol Venereol. 2009;23(6):707-708.
    1. Balato N, Gallo L, Balato A, la Bella S, Ayala F. Acrodermatitis continua of Hallopeau responding to efalizumab therapy. J Eur Acad Dermatol Venereol. 2009;23(11):1329-1330.
    1. Muggli D, Maul JT, Anzengruber F, Fopp MW, Navarini AA. Secukinumab for acrodermatitis continua of Hallopeau. JAMA Dermatol. 2017;153(4):336-337.
    1. Galluzzo M, D'Adamio S, Teoli M, Bianchi L, Talamonti M. Biologic therapy for acrodermatitis continua of Hallopeau: successful treatment with secukinumab and review of the literature. Dermatol Ther. 2019;32(3):e12899.

Substances

LinkOut - more resources